Treatment of Temporomandibular Joint (TMJ) | UHC Coverage Update

TL;DR: UnitedHealthcare modified its Medicare Advantage medical policy for TMJ treatment (policy code treatment-tmj-joint), effective February 2, 2026. Billing teams need to understand which treatment categories map to which coverage frameworks — because a single TMJ diagnosis on a claim will not get you paid.

Field	Detail
Payer	UnitedHealthcare
Policy	Treatment of Temporomandibular Joint (TMJ) – Medicare Advantage Medical Policy
Policy Code	treatment-tmj-joint
Change Type	Modified
Effective Date	February 2, 2026
Impact Level	High
Specialties Affected	Oral and maxillofacial surgery, physical therapy, pain management, DME suppliers, neurology (botulinum toxin)
Key Action	Audit TMJ claims to confirm each treatment type maps to the correct LCD, NCD, or commercial policy cross-reference before billing

UnitedHealthcare TMJ Coverage Policy: Medical Necessity Requirements 2026

The UnitedHealthcare TMJ coverage policy for Medicare Advantage members is not a single coverage rule. It is a tiered framework that routes different treatments through different coverage pathways. That distinction matters enormously for your billing team.

The core principle is this: a TMJ diagnosis code alone is not enough. The treatment-tmj-joint policy is explicit — the actual condition or symptom must be documented and determined. Medicare's statutory exclusion under §1862(a)(1) bars payment for items and services not proven reasonable and necessary. A second exclusion under §1862(a)(12) bars payment for services tied to dental structures. Either exclusion can trigger a claim denial if documentation doesn't establish the right clinical picture.

Medical necessity is not satisfied by slapping a TMJ code on a claim. Your documentation must support the specific condition being treated and the specific treatment category being billed.

Botulinum Toxins (HCPCS J0585, J0586, J0587, J0588, J0589)

Medicare has no National Coverage Determination for botulinum toxins A and B for TMJ. That means coverage here runs through Local Coverage Determinations (LCDs) and Local Coverage Articles (LCAs) at the Medicare Administrative Contractor level. Where an LCD or LCA exists, compliance is required. For states and territories with no applicable LCD or LCA, UnitedHealthcare defers to its own commercial Botulinum Toxins A and B policy.

Check your MAC's LCD status before billing J0585 through J0589 for TMJ. If you're in a region with an active LCD, that document controls — not this policy.

Corticosteroid Injections, Physical Therapy, Arthroscopy, and Arthroplasty (CPT 21240, 21242, 21247, 97039, 97139)

No NCD exists here. No LCDs or LCAs exist either. UnitedHealthcare directs coverage decisions to its commercial medical policy for Treatment of Temporomandibular Joint Disorders. That means your Medicare Advantage claims for CPT 21240 (arthroplasty, TMJ, with or without autograft), CPT 21242 (arthroplasty, TMJ, with allograft), CPT 21247 (reconstruction of mandibular condyle), and unlisted therapy codes like 97039 and 97139 get evaluated against commercial standards — not a Medicare NCD.

This is where most billing teams get tripped up. They assume Medicare Advantage follows Medicare fee-for-service rules on everything. For TMJ, it does not. The absence of an NCD means UnitedHealthcare's own commercial criteria fill the gap.

Sodium Hyaluronate Injections (HCPCS J7320–J7332)

Same situation as corticosteroids and arthroplasty. No NCD, no LCDs or LCAs. Coverage defers to the UnitedHealthcare Commercial Medical Benefit Drug Policy for Sodium Hyaluronate. If you bill J7321 (Hyalgan or Supartz), J7323 (Euflexxa), J7324 (Orthovisc), or any of the other hyaluronate codes listed in this policy, the commercial drug policy determines reimbursement eligibility.

Orthognathic Surgery (CPT 21141–21246)

No NCD, no LCDs or LCAs. Coverage guidance comes from the UnitedHealthcare commercial policy for Orthognathic (Jaw) Surgery. The full suite of LeFort I, II, and III reconstructions — CPT 21141 through 21160 — plus mandibular reconstructions, osteotomies, and bone graft codes (CPT 21188 through 21246) all route through that commercial policy. Prior authorization requirements for these procedures are almost certainly embedded there. Verify prior auth requirements before scheduling any orthognathic procedure under Medicare Advantage.

Oral Medications

These are not covered under the medical benefit. They route to Part D. Contact Prescription Solutions customer service for UnitedHealthcare Part D coverage eligibility.

DME (HCPCS E1700–E1702, E0849, E0855)

Jaw motion rehabilitation systems and traction equipment route to the UnitedHealthcare Medicare Advantage Medical Policy for Durable Medical Equipment (DME), Prosthetics, Orthotics, Nutritional Therapy, and Medical Supplies Grid. Billing these under the TMJ policy directly is a mistake. Use the DME grid policy.

UnitedHealthcare TMJ Exclusions and Non-Covered Indications

Dental and orthodontic appliances are explicitly excluded. The policy bars payment for "application of dental/orthodontic devices/appliances whether or not it accompanies oral and/or orthognathic surgery." The only exception is when these appliances are used specifically for TMJ disorder treatment — and that exception must be clearly documented.

This exclusion has teeth. Medicare's §1862(a)(12) statutory exclusion on dental-related services is the legal basis. If a claim involves a device or appliance, and your documentation doesn't clearly separate the TMJ disorder context from general dental treatment, expect a denial.